70 related articles for article (PubMed ID: 18434949)
21. Protests may slow down trials.
AIDS Patient Care STDS; 2005 Aug; 19(8):539-40. PubMed ID: 16124848
[No Abstract] [Full Text] [Related]
22. FDA notifications. Tenofovir in India receives tentative approval.
AIDS Alert; 2009 Jun; 24(6):70-1. PubMed ID: 19544609
[No Abstract] [Full Text] [Related]
23. Tenofovir DF trial announced by Gilead.
Eagan L
Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
[No Abstract] [Full Text] [Related]
24. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
25. New treatment approved for chronic hepatitis B.
FDA Consum; 2002; 36(6):4-5. PubMed ID: 12523284
[No Abstract] [Full Text] [Related]
26. Tenofovir in chronic hepatitis B.
Del Poggio P; Jamoletti C; Zaccanelli M
Hepatology; 2005 May; 41(5):1199-200; author reply 1200. PubMed ID: 15841450
[No Abstract] [Full Text] [Related]
27. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
[No Abstract] [Full Text] [Related]
28. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
29. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
Taéron C
Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
[No Abstract] [Full Text] [Related]
30. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
31. FDA notifications. New treatment approved for chronic hepatitis B.
AIDS Alert; 2002 Nov; 17(11):146-7. PubMed ID: 12412570
[No Abstract] [Full Text] [Related]
32. Drug therapy: tenofovir.
Lok AS
Hepatology; 2010 Aug; 52(2):743-7. PubMed ID: 20597070
[No Abstract] [Full Text] [Related]
33. [Treatment of chronic hepatitis B].
Clausen MR
Ugeskr Laeger; 2008 Nov; 170(48):3934. PubMed ID: 19087729
[No Abstract] [Full Text] [Related]
34. FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults.
AIDS Alert; 2005 Jul; 20(7):83-4. PubMed ID: 16114113
[No Abstract] [Full Text] [Related]
35. Hepatitis B virus viral load and treatment decision.
Tillmann H; Patel K; McHutchison J
Hepatology; 2009 Feb; 49(2):699; author reply 701-2. PubMed ID: 19177581
[No Abstract] [Full Text] [Related]
36. Prevention trials starting.
AIDS Patient Care STDS; 2004 Jun; 18(6):366-7. PubMed ID: 15384199
[No Abstract] [Full Text] [Related]
37. Five-year data out on Viread.
AIDS Patient Care STDS; 2006 Dec; 20(12):887-8. PubMed ID: 17219618
[No Abstract] [Full Text] [Related]
38. Expert review of drug patent applications: improving health in the developing world.
Amin T; Rajkumar R; Radhakrishnan P; Kesselheim AS
Health Aff (Millwood); 2009; 28(5):w948-56. PubMed ID: 19706627
[TBL] [Abstract][Full Text] [Related]
39. Chemoprophylaxis of HIV infection: moving forward with caution.
Grant RM; Wainberg MA
J Infect Dis; 2006 Oct; 194(7):874-6. PubMed ID: 16960773
[No Abstract] [Full Text] [Related]
40. An omission in the AASLD Practice Guidelines on Chronic Hepatitis B.
Jhaveri R; Murray N
Hepatology; 2007 Jul; 46(1):280; author reply 280. PubMed ID: 17596892
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
